Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average ... (t the center of it" said Mark Bard ...)

Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician

Date:9/16/2009

t the center of it," said Mark Bard, President of Manhattan Research. "The findings also highlight the need to further refine a professional strategy based on the needs of individual physician specialist segments. Clearly, companies can't use a one-size-fits-all approach when addressing a physician audience online."

Physician Specialist Segmentation Modules

Manhattan Research provides comprehensive analyses of over twenty physician specialist groups. Each Specialist Segmentation Module is an in-depth view of a particular market's adoption and use of the Internet and other technologies for clinical, treatment, and product decisions and focuses heavily on tactical execution. The segmentation modules provide clients with the necessary market data and insights to make better informed decisions during brand planning and to connect with a particular specialist group through digital strategies.

Physician specialist module topics include interactive detailing, Web 2.0, pharmaceutical customer service portals, tech-enabled sales reps, search engines, online and offline professional information sources, email use and opportunity, patient interaction and education, digital health infrastructure, and mobile technology profile.

Complimentary Specialist Digital Report Card

Are you curious as to how your target specialist group stacks up to the digital adoption trends of physicians overall? To request a complimentary digital report card of your specialist segment, and to view a list of available physician specialist segmentation modules and topics, please visit http://www.manhattanresearch.com/products/Specialist_Segmentations

For additional segmentation module product and purchasing information, please contact sales@manhattanresearch.com or call 1.888.680.0800, ext 2.

Abou
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
2. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
3. Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum
4. ASCO Results: Oncologists Rank Genentech Number One
5. Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists
6. Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
7. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
8. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
9. BIO Visitors Bring Viral Preparedness to Atlanta
10. CIRM Completes Briefing Visit to Stemedica Cell Technologies
11. Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich

Post Your Comments:

(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) ... and fiscal year ended October 31, 2009. Revenues for ... $90.4 million in the fourth quarter of fiscal 2008. ... share, for the fourth quarter of fiscal 2009, a ... diluted share, in last year,s fourth quarter. The ...

(Date:12/16/2009)... microgears in suspended solution by swimming , ... ... Scientists at the U.S. Department of Energy’s (DOE) Argonne National ... bacteria can turn microgears when suspended in a solution, providing ... , , ,“The gears are a million times more massive ...

(Date:12/16/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, according to responses from surveyed ... (both interleukin inhibitors) will capture 22 percent of ... market for moderate to severe psoriasis. Among these ... nearly three times as much patient share as ...

(Date:12/16/2009)... to Special Protocol Assessment with the Food ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... a global biopharmaceutical company focused on oncology ... by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ... clinical trial for perifosine (KRX-0401), the Company,s ...

[0] Martek Announces Fourth Quarter and FY 2009 Financial Results [0] Argonne Scientists Use Bacteria to Power Simple Machines [0] In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market [0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma

... Specimen Management Provide FocusMEMPHIS, Tenn., April 22 ... Accelerated Community Oncology Research Network, Inc. (ACORN) and ... human tissue samples for scientific research. In ... storage in conjunction with clinical trial operations and ...

... Calif., April 22 Metabolex, Inc., a biopharmaceutical company ... therapeutics for the treatment of diabetes and related metabolic ... to its Board of Directors. Mr. von Emster currently ... November 2000 to March 2009, Mr. von Emster was ...

... Inc., a leading provider of software and databases for ... that the University of Cardiff has become a certified ... access to GeneGo,s MetaCore, training and advanced support. ... with GeneGo to provide a pathway analysis environment for ...

Other Biology Technology:World BioBank(TM) Launch Benefits Advanced Medical Research 2 World BioBank(TM) Launch Benefits Advanced Medical Research 3 Metabolex Announces Election of Kurt von Emster to Board of Directors 2 Cardiff University Becomes a GeneGo Center of Excellence 2

World BioBank(TM) Launch Benefits Advanced Medical Research Metabolex Announces Election of Kurt von Emster to Board of Directors Cardiff University Becomes a GeneGo Center of Excellence

(Date:12/16/2009)... that short-term, seasonal exposure to pesticides in rivers ... of wild salmon populations. In addition to the ... that exposure to commonly used pesticides may further ... , "Major efforts are currently underway to ... recover depressed populations," says David Baldwin of the ...

(Date:12/16/2009)... a global provider of business process outsourcing (BPO) services, ... Awards Top 100 IT project of 2009 for its ... for iQor. ,, "We are honored to be recognized ... president and CEO of iQor. "TeQ21 is completely transforming ... faster, smarter and with the added security biometrics provides. ...

(Date:12/16/2009)... N.J., Dec. 3 BIO-key International, ... in wireless public safety and finger-based biometric ... its shareholders at a Special Shareholder Meeting ... company,s Law Enforcement Division to Interact911 Mobile ... were cast in favor and 1.2% were ...

Breaking Biology News(10 mins):Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2 iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 Concussion experts 3A For kids no sports no schoolwork no text messages 48183 1 Concussion experts 3A For kids no sports no schoolwork no text messages 48183 2 New research program BioInterfaces launched 8742 1 New research program BioInterfaces launched 8742 2 Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1 Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2

[0] Even at sublethal levels, pesticides may slow the recovery of wild salmon populations [0] iQor Named to InfoWorld 100 List of Top IT Projects of 2009 [0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division

... salt cedar eatersthan beetles from Greece. At least ... Uzbekistan salt cedar beetles being released by the ... those released onthe salt cedar stands near Lake ... said Vanessa Carney, Experiment Station entomologyresearch associate. , ...

... may have broader implications for understanding kidney disorders, ... have identified a second gene that gives rise ... affects multiple organs. The Children's Hospital team previously ... , The researchers found that mutations in the ...

... arterial blockages related to diabetes, smoking, obesity and ... rate. Yet physicians may be too quick to ... preventable, according to the International Diabetes Foundation. , ... are more dangerous and more expensive than revascularization, ...

Other Biology News:Better beetle sought for salt cedar control 2 Better beetle sought for salt cedar control 3 Gene discovery may shed light on kidney disease 2 Epidemic of unneeded amputations 2

Better beetle sought for salt cedar control Gene discovery may shed light on kidney disease Epidemic of unneeded amputations

... The pYD1 Yeast Display Vector is specifically ... on the surface of Saccharomyces cerevisiae. Displayed ... to interact with known or putative ligands. ... which consists of two domains Aga1 and ...

... (Aph-1aL,S Loop 92-115), O2F1 Affinity Purified ... multiprotein complex consisting of presenilin, nicastrin, ... are necessary for full proteolytic activity. ... of a number of integral membrane ...

TGase3 (S-20)...

Mouse monoclonal [HYB 232-02] to Protein S ( Abpromise for all tested applications). entrezGeneID: 5627 SwissProtID: P07225...

Biology Products:

EBY100 S. cerevisiae Strain from Invitrogen Rabbit Anti-Aph-1aL, S Loop (92-115) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc Goat Anti-TGase3 (S-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam

Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average ...(t the center of it" said Mark Bard ...)